2020 IPO
AbCellera Biologics Stock
Antibody therapeutics
Sign up today and learn more about AbCellera Biologics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About AbCellera Biologics Stock
AbCellera Biologics offers development of antibody therapeutics to improve patient outcomes.
Funding History
September 2013 | $0 |
---|---|
August 2014 | $0 |
January 2017 | $0 |
April 2017 | $818K |
September 2018 | $10.0M |
March 2019 | $4.8M |
Management
Co-Founder
Kevin Heyries
Co-Founder & Director
VĂ©ronique Lecault